# Emily A. DiMango, M.D. – FDA Inspection, Oct 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/emily-a-dimango-md/0763556d-13e4-44ee-b15f-eb778450517d
Source feed: FDA_Inspections

> FDA inspection 1027368 of Emily A. DiMango, M.D., October 02, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1027368
- Company Name: Emily A. DiMango, M.D.
- Inspection Date: 2017-10-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1246415 - 2024-08-13](https://www.keypedia.com/records/fda_inspections/emily-a-dimango-md/93c446b7-105f-4e4c-af5e-d69dfb44087e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tara-k-carmody/1895f38a-3df6-43c3-819b-829f14f5921f)

Company: https://www.keypedia.com/companies/emily-a-dimango-md/67c89259-5c4d-4f1d-a3c9-f1ef059170e1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
